Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Tuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent1. Despite chemotherapy, the global tuberculosis epidemic